Dr. Sofia Merajver received a doctoral degree in physics from the University of Maryland and a medical degree from the University of Michigan. She completed a residency in internal medicine and a fellowship in oncology at the University of Michigan before joining the faculty in 1994.
Dr. Merajver, a renowned expert in breast cancer genetics, is the medical director of the Breast and Ovarian Cancer Risk Evaluation Program at the U-M Comprehensive Cancer Center. Her research interests include the molecular genetics of breast cancer, gene function and cancer risk assessment.
She is also the director of the Inflammatory Breast Cancer Clinic and is an international leader in research into this very aggressive type of breast cancer.
